COLGATE-PALMOLIVE COMPANY Revenues
COLGATE-PALMOLIVE COMPANY (CL) reported Revenues of $4.00 billion for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-27.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2018-04-27
- COLGATE-PALMOLIVE COMPANY revenues for the quarter ending 2018-03-31 was $4.00B, a 6.38% increase year-over-year.
- COLGATE-PALMOLIVE COMPANY revenues for the quarter ending 2017-12-31 was $3.89B, a 4.60% increase year-over-year.
- COLGATE-PALMOLIVE COMPANY revenues for the quarter ending 2017-09-30 was $3.97B, a 2.77% increase year-over-year.
- COLGATE-PALMOLIVE COMPANY revenues for the quarter ending 2017-06-30 was $3.83B, a 0.49% decline year-over-year.
- COLGATE-PALMOLIVE COMPANY revenues for fiscal 2017 was $15.45B, a 1.70% increase from fiscal 2016.
- COLGATE-PALMOLIVE COMPANY revenues for fiscal 2016 was $15.20B, a 5.23% decline from fiscal 2015.
- COLGATE-PALMOLIVE COMPANY revenues for fiscal 2015 was $16.03B, a 7.19% decline from fiscal 2014.
- COLGATE-PALMOLIVE COMPANY revenues for fiscal 2014 was $17.28B, a 0.82% decline from fiscal 2013.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2018-03-31 | $4.00B 10-Q · filed 2018-04-27 | $7.89B derived: sum of 2 quarters · filed 2018-04-27 | $11.87B derived: sum of 3 quarters · filed 2018-04-27 | $15.69B derived: sum of 4 quarters · filed 2018-04-27 |
| 2017-12-31 | $3.89B derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-02-21 | $7.87B derived: sum of 2 quarters · filed 2018-02-21 | $11.69B derived: sum of 3 quarters · filed 2018-02-21 | $15.45B 10-K/A · filed 2018-02-21 |
| 2017-09-30 | $3.97B 10-Q · filed 2017-10-27 | $7.80B derived: sum of 2 quarters · filed 2017-10-27 | $11.56B 10-Q · filed 2017-10-27 | $15.28B derived: sum of 4 quarters · filed 2018-04-27 |
| 2017-06-30 | $3.83B 10-Q · filed 2017-07-21 | $7.59B 10-Q · filed 2017-07-21 | $11.31B derived: sum of 3 quarters · filed 2018-04-27 | $15.18B derived: sum of 4 quarters · filed 2018-04-27 |
| 2017-03-31 | $3.76B 10-Q · filed 2018-04-27 | $7.48B derived: sum of 2 quarters · filed 2018-04-27 | $11.35B derived: sum of 3 quarters · filed 2018-04-27 | $15.20B derived: sum of 4 quarters · filed 2018-04-27 |
| 2016-12-31 | $3.72B derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-02-21 | $7.59B derived: sum of 2 quarters · filed 2018-02-21 | $11.43B derived: sum of 3 quarters · filed 2018-02-21 | $15.20B 10-K/A · filed 2018-02-21 |
| 2016-09-30 | $3.87B 10-Q · filed 2017-10-27 | $7.71B derived: sum of 2 quarters · filed 2017-10-27 | $11.47B 10-Q · filed 2017-10-27 | $15.37B derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-06-30 | $3.85B 10-Q · filed 2017-07-21 | $7.61B 10-Q · filed 2017-07-21 | $11.51B derived: sum of 3 quarters · filed 2018-02-21 | $15.51B derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-03-31 | $3.76B 10-Q · filed 2017-04-28 | $7.66B derived: sum of 2 quarters · filed 2018-02-21 | $11.66B derived: sum of 3 quarters · filed 2018-02-21 | $15.73B derived: sum of 4 quarters · filed 2018-02-21 |
| 2015-12-31 | $3.90B derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-02-21 | $7.90B derived: sum of 2 quarters · filed 2018-02-21 | $11.96B derived: sum of 3 quarters · filed 2018-02-21 | $16.03B 10-K/A · filed 2018-02-21 |
| 2015-09-30 | $4.00B 10-Q · filed 2016-10-27 | $8.06B derived: sum of 2 quarters · filed 2016-10-27 | $12.13B 10-Q · filed 2016-10-27 | $16.36B derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $4.07B 10-Q · filed 2016-07-28 | $8.14B 10-Q · filed 2016-07-28 | $12.36B derived: sum of 3 quarters · filed 2017-02-23 | $16.74B derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $4.07B 10-Q · filed 2016-04-28 | $8.29B derived: sum of 2 quarters · filed 2017-02-23 | $12.67B derived: sum of 3 quarters · filed 2017-02-23 | $17.02B derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $4.22B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $8.60B derived: sum of 2 quarters · filed 2017-02-23 | $12.95B derived: sum of 3 quarters · filed 2017-02-23 | $17.28B 10-K · filed 2017-02-23 |
| 2014-09-30 | $4.38B 10-Q · filed 2015-10-30 | $8.73B derived: sum of 2 quarters · filed 2015-10-30 | $13.06B 10-Q · filed 2015-10-30 | $17.42B derived: sum of 4 quarters · filed 2016-02-18 |
| 2014-06-30 | $4.35B 10-Q · filed 2015-07-30 | $8.68B 10-Q · filed 2015-07-30 | $13.04B derived: sum of 3 quarters · filed 2016-02-18 | $17.44B derived: sum of 4 quarters · filed 2016-02-18 |
| 2014-03-31 | $4.33B 10-Q · filed 2015-04-30 | $8.69B derived: sum of 2 quarters · filed 2016-02-18 | $13.08B derived: sum of 3 quarters · filed 2016-02-18 | $17.43B derived: sum of 4 quarters · filed 2016-02-18 |
| 2013-12-31 | $4.36B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-18 | $8.76B derived: sum of 2 quarters · filed 2016-02-18 | $13.11B derived: sum of 3 quarters · filed 2016-02-18 | $17.42B 10-K · filed 2016-02-18 |
| 2013-09-30 | $4.40B 10-Q · filed 2014-10-24 | $8.74B derived: sum of 2 quarters · filed 2014-10-24 | $13.06B 10-Q · filed 2014-10-24 | $17.34B derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-06-30 | $4.35B 10-Q · filed 2014-07-31 | $8.66B 10-Q · filed 2014-07-31 | $12.95B derived: sum of 3 quarters · filed 2015-02-19 | $17.28B derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-03-31 | $4.32B 10-Q · filed 2014-04-25 | $8.60B derived: sum of 2 quarters · filed 2015-02-19 | $12.93B derived: sum of 3 quarters · filed 2015-02-19 | $17.20B derived: sum of 4 quarters · filed 2015-02-19 |
| 2012-12-31 | $4.29B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $8.62B derived: sum of 2 quarters · filed 2015-02-19 | $12.88B derived: sum of 3 quarters · filed 2015-02-19 | $17.09B 10-K · filed 2015-02-19 |
| 2012-09-30 | $4.33B 10-Q · filed 2013-10-24 | $8.60B derived: sum of 2 quarters · filed 2013-10-24 | $12.80B 10-Q · filed 2013-10-24 | |
| 2012-06-30 | $4.27B 10-Q · filed 2013-07-25 | $8.47B 10-Q · filed 2013-07-25 | ||
| 2011-12-31 | $16.73B 10-K · filed 2014-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kenvue Inc. (KVUE) | United States | $33.844B | 22.14 |
| e.l.f. Beauty, Inc. (ELF) | United States | $5.934B | |
| INTERPARFUMS INC (IPAR) | United States | $3.707B | 21.36 |
| COTY INC. (COTY) | United States | $2.307B | -3.15 |
| EDGEWELL PERSONAL CARE Co (EPC) | United States | $1.261B | -13.27 |
| SOLESENCE, INC. (SLSN) | United States | $0.058B | -25.13 |
| Axil Brands, Inc. (AXIL) | United States | $0.042B | 17.24 |
| UNITED GUARDIAN INC (UG) | United States | $0.034B | 13.30 |
| Caring Brands, Inc. (CABR) | United States | $0.013B | |
| BONK, INC. (BNKK) | United States | $0.011B | -0.14 |